Merck KGaA to pay over $3M to patients after drug formulation change-up triggered complaints
Ending a five-year saga, France’s highest court has ordered Merck KGaA to pay out more than $3.6 million to more than …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
